Evaluating Clinical Course and Risk Factors of Infection and Demographic Characteristics of Pregnant Women with COVID-19 in Hamadan Province, West of Iran.
Adolescent
Adult
Betacoronavirus
COVID-19
Comorbidity
Coronavirus Infections
/ complications
Cough
/ epidemiology
Demography
Dyspnea
/ epidemiology
Female
Fever
/ epidemiology
Hospitalization
Humans
Infant, Newborn
Iran
/ epidemiology
Pandemics
Pneumonia, Viral
/ complications
Pregnancy
Pregnancy Complications, Infectious
/ epidemiology
Premature Birth
Retrospective Studies
Risk Factors
SARS-CoV-2
Tomography, X-Ray Computed
Travel
Young Adult
COVID-19
Coronavirus
Demography
Pregnant Women
Risk Factors
Journal
Journal of research in health sciences
ISSN: 2228-7809
Titre abrégé: J Res Health Sci
Pays: Iran
ID NLM: 101480094
Informations de publication
Date de publication:
17 Aug 2020
17 Aug 2020
Historique:
received:
09
06
2020
accepted:
11
08
2020
revised:
29
07
2020
entrez:
10
11
2020
pubmed:
11
11
2020
medline:
21
11
2020
Statut:
epublish
Résumé
COVID-19 is a new viral disease with a rapid outbreak. Pregnant women are at a higher risk of contracting viral infections including COVID-19. We aimed to evaluate the clinical course and risk factors of pregnant women diagnosed with COVID 19 in Hamadan Province, west of Iran. A retrospective cohort study. The convenience sampling was performed using 50 papers and electronic files of pregnant women diagnosed with COVID-19 according to the WHO's temporary guidelines. They were hospitalized in health centers and clinics of Hamadan Province. The data-collecting tool employed was a researcher-made questionnaire. The data were analyzed via SPSS software version 19. The mean age of pregnant women with COVID 19 was estimated to be 29.20 ± 5.8 yr and their average gestational age estimated to be 28.8 ± 8.20 weeks. About 32% of them had an underlying disease, 32% a history of influenza, and 40% recently traveled to infected areas. The most common findings were CT scans and multiple mottling and ground-glass opacity chest radiology. The most common symptoms were fever, cough, and shortness of breath. About 8% of the women required ICU hospitalization and the average length of hospital stay was 4.04 ± 2.38 and 29% had premature births. Moreover, 28% of infected mothers had a normal delivery and 20% had a cesarean section. Early diagnosis of Covid-19 disease is essential in pregnant women. Because there is a possibility of worsening complications in the mother and fetus.
Sections du résumé
BACKGROUND
BACKGROUND
COVID-19 is a new viral disease with a rapid outbreak. Pregnant women are at a higher risk of contracting viral infections including COVID-19. We aimed to evaluate the clinical course and risk factors of pregnant women diagnosed with COVID 19 in Hamadan Province, west of Iran.
STUDY DESIGN
METHODS
A retrospective cohort study.
METHODS
METHODS
The convenience sampling was performed using 50 papers and electronic files of pregnant women diagnosed with COVID-19 according to the WHO's temporary guidelines. They were hospitalized in health centers and clinics of Hamadan Province. The data-collecting tool employed was a researcher-made questionnaire. The data were analyzed via SPSS software version 19.
RESULTS
RESULTS
The mean age of pregnant women with COVID 19 was estimated to be 29.20 ± 5.8 yr and their average gestational age estimated to be 28.8 ± 8.20 weeks. About 32% of them had an underlying disease, 32% a history of influenza, and 40% recently traveled to infected areas. The most common findings were CT scans and multiple mottling and ground-glass opacity chest radiology. The most common symptoms were fever, cough, and shortness of breath. About 8% of the women required ICU hospitalization and the average length of hospital stay was 4.04 ± 2.38 and 29% had premature births. Moreover, 28% of infected mothers had a normal delivery and 20% had a cesarean section.
CONCLUSION
CONCLUSIONS
Early diagnosis of Covid-19 disease is essential in pregnant women. Because there is a possibility of worsening complications in the mother and fetus.
Identifiants
pubmed: 33169720
pii: 5746
doi: 10.34172/jrhs.2020.22
pmc: PMC7585766
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00488Références
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
Ultrasound Obstet Gynecol. 2020 Apr;55(4):435-437
pubmed: 32134165
Ultrasound Obstet Gynecol. 2020 May;55(5):586-592
pubmed: 32180292
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Arch Acad Emerg Med. 2020 Mar 23;8(1):e34
pubmed: 32232217
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Int J Infect Dis. 2020 Jun;95:376-383
pubmed: 32353549
EClinicalMedicine. 2020 Aug;25:100446
pubmed: 32838230
J Res Health Sci. 2020 May 17;20(2):e00478
pubmed: 32814695
Fetal Diagn Ther. 2020;47(7):519-528
pubmed: 32535599
Zhonghua Fu Chan Ke Za Zhi. 2020 Mar 25;55(3):166-171
pubmed: 32145714
J Pharm Anal. 2020 Apr;10(2):102-108
pubmed: 32282863
Int J Epidemiol. 2020 Jun 1;49(3):717-726
pubmed: 32086938
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Microbiol Immunol Infect. 2019 Jun;52(3):501-503
pubmed: 29907538
Clin Infect Dis. 2020 Jul 28;71(15):844-846
pubmed: 32119083
Nature. 2016 Mar 3;531(7592):118-21
pubmed: 26935699
Radiology. 2020 Aug;296(2):E15-E25
pubmed: 32083985
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680